XML 19 R7.htm IDEA: XBRL DOCUMENT v3.21.1
Condensed Consolidated Statements of Shareholders' Equity (Deficit) - USD ($)
$ in Thousands
Total
Common Stock
Unrecognized Gains (Losses) on Derivative Instruments
Pension Obligations
Cumulative Translation Adjustment
Retained Earnings
Beginning of period at Dec. 31, 2019 $ 251,690 $ 93,331 $ 9,951 $ (5,571) $ (104,458) $ 258,437
Beginning of the period (in shares) at Dec. 31, 2019   25,128,158        
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income (loss) (190,082)         (190,082)
Change in unrecognized gains/losses on derivative instruments, net of tax (45,297)   (45,297)      
Change in defined benefit plans, net of taxes 55     55    
Net foreign currency translation adjustment (35,533)       (35,533)  
Common stock issued, net of shares withheld for employee taxes (in shares)   346,319        
Stock-based compensation (653) $ (653)        
Redeemable preferred 9% dividend and accretion (7,850)         (7,850)
European non-controlling redeemable equity dividend (20)         (20)
End of period at Mar. 31, 2020 (27,690) $ 92,678 (35,346) (5,516) (139,991) 60,485
End of the period (in shares) at Mar. 31, 2020   25,474,477        
Beginning of period at Dec. 31, 2019 251,690 $ 93,331 9,951 (5,571) (104,458) 258,437
Beginning of the period (in shares) at Dec. 31, 2019   25,128,158        
End of period at Dec. 31, 2020 $ (21,522) $ 95,247 (1,738) (7,447) (90,261) (17,323)
End of the period (in shares) at Dec. 31, 2020 25,591,930 25,591,930        
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income (loss) $ 13,122         13,122
Change in unrecognized gains/losses on derivative instruments, net of tax (8,462)   (8,462)      
Change in defined benefit plans, net of taxes 76     76    
Net foreign currency translation adjustment (15,678)       (15,678)  
Common stock issued, net of shares withheld for employee taxes (in shares)   355,532        
Stock-based compensation 505 $ 505        
Redeemable preferred 9% dividend and accretion (8,290)         (8,290)
European non-controlling redeemable equity dividend (13)         (13)
End of period at Mar. 31, 2021 $ (40,262) $ 95,752 $ (10,200) $ (7,371) $ (105,939) $ (12,504)
End of the period (in shares) at Mar. 31, 2021 25,947,462 25,947,462